Search

Taosheng Yajun Ni Chen

from Germantown, TN
Age ~60
Get Report
Also known as:
Tahshen Chen, Chen Taosheng, G Chen
Phone and address:
9580 Andora Valley Cv, Memphis, TN 38139
(203) 272-4825
Related to:
Jiayi Chen, 33Jin Chen, 37
Connected to:
Abre G Chen, 65Adele Chen, 52Adeline K Chen, 39Ai M Chen, 60Ai C Chen, 79Aiping Chen, 63Alen Y Chen, 68Alma Chen, 29Amanda Chen, 44Amanda T Chen, 62

Taosheng Chen Phones & Addresses

  • 9580 Andora Valley Cv, Germantown, TN 38139 (203) 272-4825
  • Memphis, TN
  • Hamden, CT
  • Cordova, TN
  • Arlington, TN
  • Frederick, MD
  • Cheshire, CT
  • Burlington, VT
  • Colchester, VT
  • 9580 Andorra Valley Cv, Germantown, TN 38139 (203) 228-4947

Work

Company: Center for scientific review (csr) Jul 2018 Position: Chairperson, drug discovery and molecular pharmacology study section, nih

Education

School / High School: University of Virginia School of Medicine 1996 to 1998

Skills

Drug Discovery • Molecular Biology • Cell Biology • Protein Expression • Molecular Genetics

Industries

Biotechnology

Resumes

Resumes

Taosheng Chen Photo 1

Full Member Of Chemical Biology And Therapeutics, Director Of Htb Center

View page
Location:
Germantown, TN
Industry:
Biotechnology
Work:
Center For Scientific Review (Csr)
Chairperson, Drug Discovery and Molecular Pharmacology Study Section, Nih
Slas (Society For Laboratory Automation and Screening) Jan 2016 - Feb 2018
Session Chair, Track Chair and Scientific Program Committee Member, Annual International Conference
St. Jude Children's Research Hospital Jan 2016 - Feb 2018
Full Member of Chemical Biology and Therapeutics, Director of Htb Center
Bristol-Myers Squibb 2000 - 2006
Senior Research Investigator
National Cancer Institute (Nci) 1998 - 2000
Research Scientist
Education:
University of Virginia School of Medicine 1996 - 1998
The Robert Larner, M.d. College of Medicine at the University of Vermont 1990 - 1996
Doctorates, Doctor of Philosophy, Genetics Fudan University 1987 - 1990
Master of Science, Masters, Biology Fudan University 1982 - 1987
Bachelors, Bachelor of Science, Biology
Skills:
Drug Discovery
Molecular Biology
Cell Biology
Protein Expression
Molecular Genetics

Publications

Us Patents

Methods And Compositions For The Prevention And Treatment Of Hearing Loss

View page
US Patent:
20200179397, Jun 11, 2020
Filed:
Dec 9, 2019
Appl. No.:
16/707991
Inventors:
- Memphis TN, US
Tal Teitz - Memphis TN, US
Jie Fang - Memphis TN, US
Asli Goktug - Memphis TN, US
Taosheng Chen - Germantown TN, US
Jaeki Min - Memphis TN, US
R. Kiplin Guy - Memphis TN, US
International Classification:
A61K 31/55
A61K 31/404
A61K 31/454
A61K 31/506
A61K 31/52
A61P 27/16
Abstract:
In one aspect, pharmaceutical compositions comprising a CDK2 inhibitor and one or more of at least one agent known to treat a hearing impairment and at least one agent known to prevent a hearing impairment, and methods of treating and/or preventing hearing impairments or disorders using the compositions are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Compositions And Methods For Prevention And Treatment Of Hearing Loss

View page
US Patent:
20200093923, Mar 26, 2020
Filed:
Apr 30, 2018
Appl. No.:
16/610170
Inventors:
- Memphis TN, US
Fei Zheng - Memphis TN, US
Tetsuji Yamashita - Memphis TN, US
Zoe Kellard - West Sussex, GB
Tal Teitz - Omaha NE, US
Jaeki Min - Memphis TN, US
Taosheng Chen - Germantown TN, US
Assignee:
ST. JUDE CHILDREN'S RESEARCH HOSPITALEINDHOVEN - Memphis TN
International Classification:
A61K 39/395
A61K 31/713
A61K 45/06
A61P 27/16
A61K 31/517
A61K 31/44
A61K 31/5377
A61K 31/18
A61K 31/58
A61K 31/519
A61K 31/422
A61K 31/506
A61K 31/4709
A61K 31/4706
A61K 38/17
Abstract:
Methods and compositions using an inhibitor of EGFR signaling for prevention or an inhibitor of EGFR signaling and a nucleic acid molecule encoding an atonal-associated factor for treatment of hearing loss are described.

Methods And Compositions For The Prevention And Treatment Of Hearing Loss

View page
US Patent:
20180161340, Jun 14, 2018
Filed:
Jun 20, 2016
Appl. No.:
15/580224
Inventors:
- Memphis TN, US
Tai Teitz - Memphis TN, US
Jie Fang - Memphis TN, US
Asli Goktug - Memphis TN, US
Taosheng Chen - Germantown TN, US
Jaeki Min - Memphis TN, US
R. Kiplin Guy - Memphis TN, US
International Classification:
A61K 31/55
A61K 31/52
A61K 31/404
A61K 31/506
A61K 31/454
A61P 27/16
Abstract:
In one aspect, pharmaceutical compositions comprising a CDK2 inhibitor and one or more of at least one agent known to treat a hearing impairment and at least one agent known to prevent a hearing impairment, and methods of treating and/or preventing hearing impairments or disorders using the compositions are disclosed. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Methods And Compositions Of P27Kip1 Transcriptional Modulators

View page
US Patent:
20170189477, Jul 6, 2017
Filed:
Dec 29, 2016
Appl. No.:
15/394375
Inventors:
- Memphis TN, US
Taosheng Chen - Germantown TN, US
Brandon Walters - Memphis TN, US
Bryan Kuo - Memphis TN, US
Bradley Walters - Memphis TN, US
International Classification:
A61K 38/17
C12N 5/0793
A61K 35/12
A61K 9/00
A61K 31/55
A61K 45/06
Abstract:
In one aspect, the invention relates to pharmaceutical compositions comprising agents that activate the expression of Atoh1, or pharmaceutically acceptable salts, solvates, or polymorphs thereof and agents that inhibit the expression of p27, or pharmaceutically acceptable salts, solvates, or polymorphs thereof, which are useful for inducing the formation of cochlear hair cells; and methods of treating hearing impairments or disorders using the compositions. In one aspect, the invention relates to pharmaceutical compositions comprising β-catenin; and agents that activate the expression of Atoh1, or pharmaceutically acceptable salts, solvates, or polymorphs thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Methods And Compositions Of P27Kip1 Transcriptional Modulators

View page
US Patent:
20160030445, Feb 4, 2016
Filed:
Mar 15, 2014
Appl. No.:
14/774597
Inventors:
- Memphis TN, US
Taosheng Chen - Germantown TN, US
Brandon Walters - Memphis TN, US
Bryan Kuo - Memphis TN, US
Bradley Walters - Memphis TN, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
A61K 31/55
A61K 31/05
C12N 5/071
A61K 45/06
A61K 38/17
A61K 35/12
A61K 31/44
A61K 31/222
Abstract:
In one aspect, the invention relates to pharmaceutical compositions comprising agents that activate the expression of Atoh1, or pharmaceutically acceptable salts, solvates, or polymorphs thereof; and agents that inhibit the expression of p27, or pharmaceutically acceptable salts, solvates, or polymorphs thereof, which are useful for inducing the formation of cochlear hair cells; and methods of treating hearing impairments or disorders using the compositions. In one aspect, the invention relates to pharmaceutical compositions comprising β-catenin; and agents that activate the expression of Atoh1, or pharmaceutically acceptable salts, solvates, or polymorphs thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Control profile
Taosheng Yajun Ni Chen from Germantown, TN, age ~60 Get Report